Andrew Carruthers
Co-Founder & Managing Partner @ Novastar Ventures
London, United Kingdom
Andrew Carruthers is a Series A investor at Novastar Ventures in London focused on Software and Health Care. Andrew Bruce Carruthers is based out of London, England and is the Co-Founder & Managing Partner of Novastar Ventures. Andrew previously worked at KPMG as a Assistant Director Corporate Finance. Andrew Bruce Carruthers attended the London School of Economics and Political Science.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Andrew Carruthers invests in
Stages Andrew Carruthers invests in
Countries Andrew Carruthers invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 2 (13%)
- Health Care 2 (13%)
- ISP 1 (6%)
- Solar 1 (6%)
- Energy 1 (6%)
Stage
- Series A 4 (25%)
- Series B 3 (19%)
- Funding Round 3 (19%)
- Series C 2 (13%)
- Seed 1 (6%)
Country
- United Kingdom 4 (25%)
- Ghana 1 (6%)
- Kenya 1 (6%)
- Ethiopia 1 (6%)
- The Netherlands 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Poa! provides low cost internet to individuals and small businesses in low-income neighborhoods in East Africa. poa! offers customers access to affordable and reliable data that is 40% cheaper than network operators, free content and free online services and tools.poa! services are delivered through a Wi-Fi network that blankets an entireneighborhood, enabling access to the internet on any Wi-Fi enabled device at any time. Unlike competitors, poa! offers transparent pricing, data bundles that are not time-limited and free content and online services such as job boards and marketplaces. | $28M / Series C / Jan 18, 2022 | ||
| mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly toconsumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices.The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013. | $30M / Series D / Jan 05, 2022 | ||
| Sure Chill is a pioneering platform cooling technology that continuously cools for weeks without power. It is innovative and its performance is unrivalled. By harnessing the unique properties of water, it allows continual cooling at a perfect 4ºC, anywhere in the world. The technology is saving lives today, and it can help save their planet.Vaccine Refrigerators powered by Sure Chill technology were first launched into the medical market in 2011, far exceeding the most stringent standards set by the World Health Organization. Today, they’re purchased by the likes of UNICEF, saving lives in 46 countries by protecting vaccines. It has been commended for aiding vaccine delivery in developing countries, and received a $1.5 million ‘Grand Challenges’ award from the Bill and Melinda Gates Foundation to improve the vaccine cold chain. | $2.8M / Convertible Note / Oct 20, 2020 | ||
| mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly toconsumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices.The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013. | $18.5M / Series C / May 26, 2020 | ||
| Sure Chill is a pioneering platform cooling technology that continuously cools for weeks without power. It is innovative and its performance is unrivalled. By harnessing the unique properties of water, it allows continual cooling at a perfect 4ºC, anywhere in the world. The technology is saving lives today, and it can help save their planet.Vaccine Refrigerators powered by Sure Chill technology were first launched into the medical market in 2011, far exceeding the most stringent standards set by the World Health Organization. Today, they’re purchased by the likes of UNICEF, saving lives in 46 countries by protecting vaccines. It has been commended for aiding vaccine delivery in developing countries, and received a $1.5 million ‘Grand Challenges’ award from the Bill and Melinda Gates Foundation to improve the vaccine cold chain. | $5M / Series A / Jul 19, 2019 | ||
| mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly toconsumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices.The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013. | $9.7M / Series B / Jan 10, 2019 | ||
| Poa! provides low cost internet to individuals and small businesses in low-income neighborhoods in East Africa. poa! offers customers access to affordable and reliable data that is 40% cheaper than network operators, free content and free online services and tools.poa! services are delivered through a Wi-Fi network that blankets an entireneighborhood, enabling access to the internet on any Wi-Fi enabled device at any time. Unlike competitors, poa! offers transparent pricing, data bundles that are not time-limited and free content and online services such as job boards and marketplaces. | $10M / Venture - Series Unknown / Sep 28, 2018 | ||
| GreenPath supports and improves the production of food on Partner Farms, growing greater amounts of fruit and vegetables by using organic, bio-diverse, and environmentally sustainable farming practices. Increased fruit and vegetable yields lead to higher incomes, and incentivize farmers to move away from growing less nutritious crops that requireincreasingly expensive synthetic chemicals and pesticides, that leave harmful side effects on land and human health. With more nutritious foods on their farms, our farmers also eat more healthily at home. | $1M / Series A / Apr 01, 2018 | ||
| SolarNow provides solar energy and financing solutions in East Africa through its subsidiary. It offers solar home systems, electrical appliances, and power solutions that are designed to fit the needs of rural and urban households, entrepreneurs, and institutions. SolarNow offers household, small business, farming, and corporate solutions.Willem Nolens founded it in 2011, with its headquarters in Nijmegen in the Netherlands and branch locations in Uganda and Kenya. | $9M / Series B / Dec 15, 2017 | ||
| Poa! provides low cost internet to individuals and small businesses in low-income neighborhoods in East Africa. poa! offers customers access to affordable and reliable data that is 40% cheaper than network operators, free content and free online services and tools.poa! services are delivered through a Wi-Fi network that blankets an entireneighborhood, enabling access to the internet on any Wi-Fi enabled device at any time. Unlike competitors, poa! offers transparent pricing, data bundles that are not time-limited and free content and online services such as job boards and marketplaces. | $4M / Series A / Sep 01, 2017 | ||
| See all 16 investments → | |||
Co-Investors
About Novastar Ventures
Novastar is a venture catalyst firm assisting the next generation of exceptional entrepreneurs who are designing and executing innovative business models to profitably serve East Africa’s aspiring mass market.These ‘New Stars’ are the catalysts for innovation, accountability, efficiency and the accumulation of wealth for the common good.While they are managing a pool of capital, they do not think of their selves primarily as fund managers. The fun and focus of their work is partnering with entrepreneurs to help bring ideas to life and multiply their impact.
Novastar Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Abel Boreto
Associate Investment Director
|
|||
|
Andrew Carruthers
Co-Founder & Managing Partner
|
|||
Nghi Tran
In-House Counsel
|
|||
Oluwatoyin Emmanuel-Olubake
Investment Director
|
|||
Steve Beck
Co-Founder and Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andrew Carruthers invest in?
Andrew Carruthers invests primarily in Software, Health Care and ISP startups, most often at Series A and Series B stage. Most of the 16 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Andrew Carruthers?
Public channels for Andrew Carruthers include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Andrew Carruthers last invest?
The most recent investment recorded for Andrew Carruthers closed in Jan 2022. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
